Omega-3 Fatty Acids and Cardiovascular Disease
Publisher: Agency for Healthcare Research and Quality 2016
Number of pages: 1252
There have been hundreds of observational studies and clinical trials conducted to evaluate the effect of omega-3 fatty acids (n-3 FA) on CV disease (CVD) and its risk factors and intermediate markers. The n-3 FA are a group of long-chain and very-long-chain polyunsaturated fatty acids (PUFA) that are substrates for the synthesis of eicosanoids and are important components of cell membranes that impact fluidity.
Home page url
Download or read it online for free here:
- Agency for Healthcare Research and Quality
There are two generally accepted strategies for managing atrial fibrillation (AF): rate control and rhythm control. However, within each strategic approach there are a large number of potential pharmacological and nonpharmacological therapies...
- Royal College of General Practitioners
This guideline gives recommendations to clinicians and others about lifestyle modification, cardiac rehabilitation, drug therapy and advice about which patients to refer for further assessment for possible coronary revascularisation.
- National Institute for Health and Clinical Excellence
This guideline covers the role of intensive insulin therapy in managing hyperglycaemia within the first 48 hours in people admitted to hospital for acute coronary syndromes. ACS encompass a spectrum of unstable coronary artery disease...
- National Academies Press
This book examines the complete system of response to cardiac arrest in the United States and identifies opportunities within existing and new treatments, strategies, and research that promise to improve the survival and recovery of patients.